196 related articles for article (PubMed ID: 10225560)
1. Tumour cell kinetics as a prognostic factor in squamous cell carcinoma of the cervix treated with radiotherapy.
Gasińska A; Urbański K; Jakubowicz J; Klimek M; Biesaga B; Wilson GD
Radiother Oncol; 1999 Jan; 50(1):77-84. PubMed ID: 10225560
[TBL] [Abstract][Full Text] [Related]
2. Proliferation measurements with flow cytometry Tpot in cancer of the uterine cervix: correlation between two laboratories and preliminary clinical results.
Tsang RW; Fyles AW; Kirkbride P; Levin W; Manchul LA; Milosevic MF; Rawlings GA; Banerjee D; Pintilie M; Wilson GD
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1319-29. PubMed ID: 7635771
[TBL] [Abstract][Full Text] [Related]
3. Tumour proliferation and apoptosis in human uterine cervix carcinoma II: correlations with clinical outcome.
Tsang RW; Wong CS; Fyles AW; Levin W; Manchul LA; Milosevic M; Chapman W; Li YQ; Pintilie M
Radiother Oncol; 1999 Jan; 50(1):93-101. PubMed ID: 10225562
[TBL] [Abstract][Full Text] [Related]
4. Tumor proliferation and apoptosis in human uterine cervix carcinoma I: correlations between variables.
Tsang RW; Fyles AW; Li Y; Rajaraman MM; Chapman W; Pintilie M; Wong CS
Radiother Oncol; 1999 Jan; 50(1):85-92. PubMed ID: 10225561
[TBL] [Abstract][Full Text] [Related]
5. Age and bromodeoxyuridine labelling index as prognostic factors in high-grade gliomas treated with surgery and radiotherapy.
Gasinska A; Skolyszewski J; Glinski B; Niemiec J; Adamczyk A; Krzyszkowski T; Zabek M
Clin Oncol (R Coll Radiol); 2006 Aug; 18(6):459-65. PubMed ID: 16909969
[TBL] [Abstract][Full Text] [Related]
6. Argyrophilic nucleolar organizer regions, bromodeoxyuridine labelling index and DNA ploidy in squamous cell carcinoma of the uterine cervix.
Gasińska A; Zabagło L; Cichocka A; Pudełek J; Urbański K; Skołyszewski J
Folia Histochem Cytobiol; 1996; 34(2):95-101. PubMed ID: 8875218
[TBL] [Abstract][Full Text] [Related]
7. Influence of overall treatment time and radiobiological parameters on biologically effective doses in cervical cancer patients treated with radiation therapy alone.
Gasinska A; Fowler JF; Lind BK; Urbanski K
Acta Oncol; 2004; 43(7):657-66. PubMed ID: 15545186
[TBL] [Abstract][Full Text] [Related]
8. Are increased tumor aneuploidy and heightened cell proliferation along with heterogeneity associated with patient outcome for carcinomas of the uterine cervix? A combined analysis of subjects treated in RTOG 9001 and a single-institution trial.
Wolfson AH; Winter K; Crook W; Krishan A; Grigsby PW; Markoe AM; Morris M; Gaffney DK; Eifel PJ; Lucci JA
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):111-7. PubMed ID: 17919835
[TBL] [Abstract][Full Text] [Related]
9. Treatment results of high-dose-rate remote afterloading brachytherapy for cervical cancer and retrospective comparison of two regimens.
Wong FC; Tung SY; Leung TW; Sze WK; Wong VY; Lui CM; Yuen KK; O SK
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1254-64. PubMed ID: 12654435
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of DNA ploidy and proliferation rate in human astrocytic gliomas.
Gasińska A; Krzyszk wski T; Niemiec J; Adamczyk A; Skołyszewski J
Folia Histochem Cytobiol; 2000; 38(4):175-80. PubMed ID: 11185722
[TBL] [Abstract][Full Text] [Related]
11. Figo IIIB squamous cell carcinoma of the cervix: an analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy.
Logsdon MD; Eifel PJ
Int J Radiat Oncol Biol Phys; 1999 Mar; 43(4):763-75. PubMed ID: 10098431
[TBL] [Abstract][Full Text] [Related]
12. An audit of the treatment of carcinoma of the uterine cervix using external beam radiotherapy and a single line source brachytherapy technique.
Tan LT; Jones B; Gee A; Kingston RE
Br J Radiol; 1997 Dec; 70(840):1259-69. PubMed ID: 9505845
[TBL] [Abstract][Full Text] [Related]
13. A ratio of apoptosis to mitosis, proliferation pattern and prediction of radiotherapy response in cervical carcinoma.
Gasinska A; Urbanski K; Gruchala A; Biesaga B; Kojs Z
Neoplasma; 2002; 49(6):379-86. PubMed ID: 12584585
[TBL] [Abstract][Full Text] [Related]
14. High dose-rate brachytherapy for elderly patients with uterine cervical cancer.
Chen SW; Liang JA; Yang SN; Lin FJ
Jpn J Clin Oncol; 2003 May; 33(5):221-8. PubMed ID: 12865465
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment proliferation parameters do not add predictive power to clinical factors in cervical cancer treated with definitive radiation therapy.
Tsang RW; Juvet S; Pintilie M; Hill RP; Wong CS; Milosevic M; Chapman W; Levin W; Manchul LA; Fykes AW
Clin Cancer Res; 2003 Oct; 9(12):4387-95. PubMed ID: 14555510
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometry (FCM) of early radiation response in epidermoid carcinoma of uterine cervix.
Glasová M; Siracký J; Masák L; Kysela B
Neoplasma; 1992; 39(6):353-6. PubMed ID: 1491725
[TBL] [Abstract][Full Text] [Related]
17. Micronucleus assay in vivo provides significant prognostic information in human cervical carcinoma; the updated analysis.
Widel M; Kolosza Z; Jedruś S; Lukaszczyk B; Raczek-Zwierzycka K; Swierniak A
Int J Radiat Biol; 2001 May; 77(5):631-6. PubMed ID: 11382342
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometric analysis of DNA ploidy and S-phase fraction of Stage IIIB cervical carcinoma.
Wilailak S; Rochanawutanon M; Srisupundit S; Aumkhyan A; Pattanapanyasat K
Eur J Gynaecol Oncol; 2004; 25(4):428-30. PubMed ID: 15285296
[TBL] [Abstract][Full Text] [Related]
19. DNA ploidy, grade, and stage in prognosis of uterine cervical cancer.
Davis JR; Aristizabal S; Way DL; Weiner SA; Hicks MJ; Hagaman RM
Gynecol Oncol; 1989 Jan; 32(1):4-7. PubMed ID: 2909446
[TBL] [Abstract][Full Text] [Related]
20. Prediction of radiotherapy response of cervical carcinoma through measurement of proliferation rate.
Bolger BS; Symonds RP; Stanton PD; MacLean AB; Burnett R; Kelly P; Cooke TG
Br J Cancer; 1996 Oct; 74(8):1223-6. PubMed ID: 8883408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
